ClinicalTrials.Veeva

Menu

Arthritis Self-Management Education Program

University of North Carolina (UNC) logo

University of North Carolina (UNC)

Status

Completed

Conditions

Arthritis

Treatments

Behavioral: Arthritis Quick Start
Other: Delayed treatment intervention

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT00467064
06-0398-1-3
S3521-24/24 (Other Grant/Funding Number)

Details and patient eligibility

About

We will develop brief versions of the classic 6-week Arthritis Self-Management Program and evaluate their effectiveness.

Full description

Many national statements have been made recently about the importance of evidence-based arthritis self-management to improvements in the public's health. The prevalence of arthritis is increasing as the US population ages; the prevalence of arthritis-related disability is higher among Blacks than Whites. Effective arthritis self-management education programs with varying formats have been developed and found effective. Despite this, many Arthritis Foundation chapters and arthritis units of state health departments have found dissemination difficult, and cite the time demands (6 weekly sessions, 2 hours/session) of the classic arthritis self-management education program (ASMP) as a major barrier. Researchers at the University of North Carolina at Chapel Hill and Stanford University will develop and evaluate two "low dose" arthritis self-management programs. The study will be conducted in three phases. Phase One (Development): Researchers will conduct needs assessments with arthritis self-management program disseminators, rheumatologists and other arthritis health professionals, and potential program users to determine preferred content, length, and schedule. Using findings from these assessments, researchers will develop two "low dose" versions of the ASMP. Phase Two (Implementation and Evaluation): Researchers will evaluate the "response" (effectiveness) of both "low dose" interventions in a randomized controlled trial (4 months) and a longitudinal study (one year). We will measure four outcomes: (1) Self-Management Behaviors, (2) Arthritis Self-Efficacy, (3) Health-related Quality of Life (Self-reported Health, Pain, Disability, Fatigue, Activity Limitation, and Health Distress); and (4) Health Care Utilization. A sample of 700 adults with diagnosed arthritis or chronic joint pain, including 200 African Americans, will participate in the study. All data will be gathered via self-administered mailed questionnaires, with telephone follow-up as needed. We will use analysis of co-variance and structural equation modeling to evaluate effectiveness. Researchers will also compare the effectiveness of each new "low dose" program with the effectiveness of existing arthritis self-management education program options. Phase Three (Dissemination): We will consult with arthritis units of state health departments and state chapters of the Arthritis Foundation on program adoption and distribution.

Enrollment

690 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Adults, 18 years or older
  • Arthritis diagnosis
  • No prior participation in arthritis self-management

Trial design

690 participants in 2 patient groups

Arthritis self-management workshop
Experimental group
Description:
Comparison of two-week, lay led, scripted self-management workshop emphasizing action planning, problem-solving, and content specific to arthritis.
Treatment:
Other: Delayed treatment intervention
Behavioral: Arthritis Quick Start
Delayed treatment control
Other group
Description:
After 4 month delay, participants in Control Group receive Experimental intervention.
Treatment:
Other: Delayed treatment intervention

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems